智翔金泰(688443)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

688443 智翔金泰

已收盘 07-25 15:00:01

{"stockData":{"symbol":"688443","market":"SH","secType":"STK","nameCN":"智翔金泰","latestPrice":33.43,"timestamp":1753426801000,"preClose":34.31,"halted":0,"volume":6733757,"delay":0,"changeRate":-0.0256,"floatShares":117000000,"shares":367000000,"eps":-2.057,"marketStatus":"已收盘","change":-0.88,"latestTime":"07-25 15:00:01","open":34.48,"high":34.49,"low":33.1,"amount":226000000,"amplitude":0.0405,"askPrice":33.43,"askSize":133,"bidPrice":33.42,"bidSize":32,"shortable":0,"etf":0,"ttmEps":-2.057,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1753666200000},"marketStatusCode":5,"adr":0,"adjPreClose":34.31,"symbolType":"stock_kcb","openAndCloseTimeList":[[1753407000000,1753414200000],[1753419600000,1753426800000]],"highLimit":37.74,"lowLimit":30.88,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":366680000,"isCdr":false,"pbRate":6.13,"roa":"--","roe":"--","epsLYR":-2.17,"committee":-0.365079,"marketValue":12258000000,"turnoverRate":0.0577,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2025-07-28。","afterMarket":{"amount":0,"volume":0,"close":33.43,"buyVolume":0,"sellVolume":0,"time":1753428838020,"indexStatus":"已收盘 07-25 15:30:00","preClose":34.31},"floatMarketCap":3901000000},"requestUrl":"/m/hq/s/688443","defaultTab":"news","newsList":[{"id":"2553440505","title":"智翔金泰-U涨5.29%创近1个月新高 受半年报披露及回购预案提振","url":"https://stock-news.laohu8.com/highlight/detail?id=2553440505","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553440505?lang=zh_cn&edition=full","pubTime":"2025-07-21 09:32","pubTimestamp":1753061565,"startTime":"0","endTime":"0","summary":"智翔金泰-U今日股价大幅上涨，截至09点32分，最新价为35.02元/股，涨幅达5.29%，创近1个月新高。7月18日公司披露2024年半年度报告，同步发布股价稳定预案，明确回购与董事增持规则，传递管理层信心。根据内部金融数据库，截至7月18日收盘，当日主力资金净流入5038.78万元，单日成交额达4.38亿元，资金面活跃度显著提升。当前股价已较年初上涨39.58%，技术面面临前期压力位考验，市场分歧或加剧波动。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721093558a6b67c33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250721093558a6b67c33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688443","BK0239"],"gpt_icon":0},{"id":"2552548534","title":"智翔金泰-U涨5.11%创近一个月新高 资金博弈加剧股价波动","url":"https://stock-news.laohu8.com/highlight/detail?id=2552548534","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552548534?lang=zh_cn&edition=full","pubTime":"2025-07-18 13:02","pubTimestamp":1752814928,"startTime":"0","endTime":"0","summary":"智翔金泰-U股价今日表现强势，截至13点01分，最新价报32.51元/股，涨幅达5.11%，创近一个月新高。资金博弈加剧股价波动智翔金泰-U近期净流出与资金面高频博弈密切相关。截至2025年7月16日，主力资金连续两个交易日累计净流出1417.1万元，生物制品板块同期净流出5.50亿元，板块资金吸引力下降加剧个股流动性压力。2025年一季度净利润亏损1.21亿元，叠加7.12亿美元海外授权协议首付款尚未到账，加速部分机构调仓避险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718130214a6b1411b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250718130214a6b1411b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688443","BK0239"],"gpt_icon":0},{"id":"2552117478","title":"智翔金泰-U涨5.04%创近1个月新高 创新药商业化进程推动估值修复","url":"https://stock-news.laohu8.com/highlight/detail?id=2552117478","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552117478?lang=zh_cn&edition=full","pubTime":"2025-07-17 10:01","pubTimestamp":1752717681,"startTime":"0","endTime":"0","summary":"智翔金泰-U今日股价大幅上涨，截至10点00分，最新价报31.05元，涨幅达5.04%，创近1个月新高，并成功突破30元整数关口。资金博弈与市场情绪共振智翔金泰-U近期净流出与资金面波动紧密相关。创新药商业化进程构筑估值中枢长期看，智翔金泰-U的价值锚点在于核心管线的研发转化效率。富国基金等机构认为，商业化放量可能推动股价突破年内23.71%涨幅，但需警惕临床进展不及预期风险。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717100132a44fd703&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250717100132a44fd703&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688443","159992"],"gpt_icon":0},{"id":"2551119280","title":"科创成长层改革推进 券商系统升级及风险揭示书签署有序展开","url":"https://stock-news.laohu8.com/highlight/detail?id=2551119280","media":"DoNews","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2551119280?lang=zh_cn&edition=full","pubTime":"2025-07-16 11:13","pubTimestamp":1752635582,"startTime":"0","endTime":"0","summary":"上交所方面正组织风险揭示书签署工作，并修订相关指南，新增《科创板科创成长层企业股票投资风险揭示书必备条款》，明确未盈利企业存在的各类投资风险。上交所下发通知要求券商完善适当性管理工作，包括完成风险揭示书签署及系统准备，给予投资者充分阅读时间，并通过多种渠道开展投资者教育。上交所将持续督促券商并开展监督检查。7月14日，上交所举办专题培训会，120家券商330余名相关负责人参会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071611164495444cb2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071611164495444cb2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688327","688343","688221","688322","688176","688382","688192","688302","01877","688373","06160","688197","02402","688220","688316","688266","688702","688512","BK0239","688165","000690.SH","688280","688538","09969","688549","688515","688277","688561","688256","688469","ONC","688443","688387"],"gpt_icon":0},{"id":"2550693609","title":"智翔金泰-U涨5.44% 创新药研发预期提振信心","url":"https://stock-news.laohu8.com/highlight/detail?id=2550693609","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550693609?lang=zh_cn&edition=full","pubTime":"2025-07-10 09:50","pubTimestamp":1752112243,"startTime":"0","endTime":"0","summary":"智翔金泰-U今日盘中表现强劲，截至09点50分，股价报29.86元/股，上涨5.44%，换手率1.60%，振幅同样为5.44%，成交金额达5425万元。资金博弈与政策扰动共振智翔金泰-U近期净流入与资金流动和市场风格切换密切相关。7月1日公司公告2030万元回购计划，虽金额有限却阶段性提振信心。研发兑现与融资平衡角力长期看，智翔金泰-U的估值重构取决于创新药研发进度与商业化能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710095053a44169c9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710095053a44169c9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","159992","688443"],"gpt_icon":0},{"id":"2548898866","title":"智翔金泰获批开展GR1803临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=2548898866","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548898866?lang=zh_cn&edition=full","pubTime":"2025-07-02 17:43","pubTimestamp":1751449410,"startTime":"0","endTime":"0","summary":"7月2日，智翔金泰（688443）发布公告，近日，收到国家药品监督管理局核准签发的《药物临床试验批准通知书》。GR1803注射液是一款由公司自主研发的双特异性抗体药物，具有较高的亲和力，能够同时结合抗原BCMA和CD3，从而激活T细胞杀伤肿瘤细胞。该药物的注册分类为治疗用生物制品1类，目前处于II期临床试验阶段。公告中提到，国内已有两款进口的BCMA×CD3靶点抗体药物附条件批准上市。2025年一季度，智翔金泰实现收入2016万元，归母净利润-1.21亿元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070217441697971c2f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025070217441697971c2f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688443","BK0239"],"gpt_icon":0},{"id":"2548074772","title":"智翔金泰：累计回购0.2171%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2548074772","media":"格隆汇资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548074772?lang=zh_cn&edition=full","pubTime":"2025-07-01 16:55","pubTimestamp":1751360125,"startTime":"0","endTime":"0","summary":"格隆汇7月1日丨智翔金泰(688443.SH)公布，截至2025年6月30日，公司已通过上海证券交易所交易系统以集中竞价交易方式累计回购公司股份796,100股，占公司总股本366,680,000股的比例为0.2171%，回购成交的最高价为29.43元/股，最低价为22.89元/股，支付的资金总额为人民币20,297,339.45元（不含佣金、过户费等交易费用）。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701165531953256d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701165531953256d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688443","BK0239"],"gpt_icon":0},{"id":"2548046015","title":"自免 TCE 风起云涌，中国 Biotech 差异化布局领跑全球","url":"https://stock-news.laohu8.com/highlight/detail?id=2548046015","media":"医麦客","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548046015?lang=zh_cn&edition=full","pubTime":"2025-07-01 07:20","pubTimestamp":1751325625,"startTime":"0","endTime":"0","summary":"公开数据显示，目前全球已有约 10 款 TCE 疗法获批上市，主要覆盖血液瘤与实体瘤两大领域，靶点包括 CD19、CD20、BCMA 和 GPRC5D 等。国产自免 TCE 出海潮四家 CD3/BCMA 各有千秋近一年来，MNC 在自免领域的管线争夺趋于白热化。此前，PIT565 已在国内获批临床，拟用于治疗 B 细胞恶性肿瘤。目前，PIT565 针对 B 细胞恶性肿瘤和系统性红斑狼疮两种适应症均处于 1 期临床。CC312是惠和生物基于其新一代共刺激信号 TCE 平台 TriTETM自主研发的CD19/CD3/CD28 三抗，也是全球首个获批系统性","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701072710a4c779eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250701072710a4c779eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02142","688506","BK0239","02162","688443"],"gpt_icon":0},{"id":"2547605004","title":"智翔金泰-U主力两日净流入557.1万元 研发进展左右股价走势","url":"https://stock-news.laohu8.com/highlight/detail?id=2547605004","media":"智选洞察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547605004?lang=zh_cn&edition=full","pubTime":"2025-06-30 15:28","pubTimestamp":1751268516,"startTime":"0","endTime":"0","summary":"智翔金泰-U今日主力资金净流入449.8万元，上一交易日主力净流入107.3万元。连续两个交易日呈现主力资金净流入态势，表明市场关注度提升，短期内资金面偏积极。截至6月27日，生物制品板块近20日主力净流出规模达5.50亿元，行业资金吸引力下降与板块轮动形成共振。研发突破与商业化进程决定估值中枢长期来看，智翔金泰-U的核心矛盾在于研发管线兑现能力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630154834a72585a1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630154834a72585a1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688443"],"gpt_icon":0},{"id":"2546124867","title":"智翔金泰：GR1802注射液临床开发稳步推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2546124867","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546124867?lang=zh_cn&edition=full","pubTime":"2025-06-27 18:24","pubTimestamp":1751019858,"startTime":"0","endTime":"0","summary":"证券之星消息，智翔金泰06月27日在投资者关系平台上答复投资者关心的问题。公司将严格按照信息披露规则，及时履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025062700032671.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688443","BK0239"],"gpt_icon":0},{"id":"2546837067","title":"智翔金泰-U06月26日遭主力抛售1221.8万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546837067","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546837067?lang=zh_cn&edition=full","pubTime":"2025-06-26 15:21","pubTimestamp":1750922501,"startTime":"0","endTime":"0","summary":"06月26日, 智翔金泰-U股价跌2.55%，报收28.27元，成交金额1.7亿元，换手率5.22%，振幅6.83%，量比1.37。智翔金泰-U今日主力资金净流出1221.8万元，连续3日净流出，上一交易日主力净流出3048.4万元。该股近5个交易日上涨3.48%，主力资金累计净流出3480.8万元；近20日主力资金累计净流出741.7万元，其中净流出天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626171327a4bee43f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626171327a4bee43f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688443","BK0239"],"gpt_icon":0},{"id":"2546710002","title":"机遇与挑战并存！断档2年之后，这家创新药企业将在科创板IPO上会","url":"https://stock-news.laohu8.com/highlight/detail?id=2546710002","media":"制药网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546710002?lang=zh_cn&edition=full","pubTime":"2025-06-26 11:04","pubTimestamp":1750907042,"startTime":"0","endTime":"0","summary":"根据上交所上市审核委员会发布审议会议公告，7 月 1 日，武汉禾元生物科技股份有限公司将迎来科创板 IPO 上会，拟采用科创板第五套标准上市。禾元生物的上会，再次将市场目光聚焦于创新药企业在科创板的上市之路。数据显示科创板自开板以来，共有20家创新型生物医药企业采用第五套上市标准先后在科创板上市。禾元生物是在这2年的断档期之后，一家无比接近科创板IPO的创新药企业。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626110655978f4b25&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250626110655978f4b25&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688278","159982","688180","159992","688192","688443","688578","BK0239"],"gpt_icon":0},{"id":"2546213715","title":"智翔金泰-U06月25日遭主力抛售3048.4万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546213715","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546213715?lang=zh_cn&edition=full","pubTime":"2025-06-25 15:20","pubTimestamp":1750836015,"startTime":"0","endTime":"0","summary":"06月25日，智翔金泰-U股价收平报29.01元，成交金额1.8亿元，换手率5.41%，振幅2.90%，量比1.62。智翔金泰-U今日主力资金净流出3048.4万元，上一交易日主力净流出161.0万元。该股近5个交易日上涨4.35%，主力资金累计净流出2954.5万元；近20日主力资金累计净流入1636.4万元，其中净流入天数为10日。|06月25日主力加仓幅度排名||#|股票简称|主力净额占比|#|天晟新材|11.04%|#|新力金融|7.66%|#|北方长龙|7.56%|#|...|...|#5261|智翔金泰-U|-0.90%|智翔金泰-U所在的生物制品行业，今日主力净流出3.72亿元，行业排名20/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625170121a71cb8ff&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625170121a71cb8ff&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688443","BK0239"],"gpt_icon":0},{"id":"2545549146","title":"智翔金泰-U06月23日获主力加仓513.1万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2545549146","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545549146?lang=zh_cn&edition=full","pubTime":"2025-06-23 15:20","pubTimestamp":1750663244,"startTime":"0","endTime":"0","summary":"06月23日, 智翔金泰-U股价涨4.69%，报收29.00元，成交金额1.8亿元，换手率5.52%，振幅7.40%，量比1.55。智翔金泰-U今日主力资金净流入513.1万元，上一交易日主力净流入437.3万元。该股近5个交易日下跌0.62%，主力资金累计净流入149.5万元；近20日主力资金累计净流入5626.0万元，其中净流入天数为12日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623165406a71862e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250623165406a71862e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688443"],"gpt_icon":0},{"id":"2545102436","title":"智翔金泰-U：重磅产品成功出海 迈入全球化开发新阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2545102436","media":"国盛证券","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2545102436?lang=zh_cn&edition=full","pubTime":"2025-06-22 00:00","pubTimestamp":1750521600,"startTime":"0","endTime":"0","summary":"公司近期与Cullinan Therapeutics 签署授权许可和商业化协议，就GR1803 达成独家许可与合作协议。2024 年4 月，Cullinan Oncology 宣布进行重大调整，公司更名为Cullinan Therapeutics，并将CD3/CD19 双抗CLN-978 纳入核心研发管线，适应症从血液瘤调整为自身免疫疾病。公司国内海外各条业务线均快速拓展。看好公司长期发展，维持“买入”评级。公司龙头产品赛立奇单抗于2024 年8 月上市，预计将于2025 年参加医保谈判。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250622150156a716e1e9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250622150156a716e1e9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688443"],"gpt_icon":0},{"id":"2544192772","title":"生物制品行业深度报告：MNC加速布局减重降糖千亿美金赛道，开启BD黄金窗口期","url":"https://stock-news.laohu8.com/highlight/detail?id=2544192772","media":"开源证券","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544192772?lang=zh_cn&edition=full","pubTime":"2025-06-20 08:06","pubTimestamp":1750377989,"startTime":"0","endTime":"0","summary":"MNC加速布局减重降糖千亿美金赛道，开启BD黄金窗口期以司美格鲁肽与替尔泊肽为代表的GLP-1RA类药物正在彻底改变糖尿病与肥胖症的治疗范式，根据Jefferies等数据统计，2031年预计GLP-1RA类药物全球销售规模有望超过1500亿美元规模。近年来减重降糖领域重磅BD交易频发，我们预期将迎来BD黄金窗口期，国内企业相关管线将迎来历史性出海机遇。随着海外MNC加速布局该赛道，国内优质管线均有较强出海潜力，有望打开成长空间。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506200806389523e82d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506200806389523e82d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["603392","688331","688488","688136","688336","600161","688276","BK0239","603590","688293","688670","603087","688520","688137","688319","688739","688105","159831","688177","688687","600867","688185","600739","BK0033","688278","688443","600211","688163","688180"],"gpt_icon":0},{"id":"2544157589","title":"智翔金泰-U06月19日主力净流出695.5万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2544157589","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544157589?lang=zh_cn&edition=full","pubTime":"2025-06-19 15:21","pubTimestamp":1750317681,"startTime":"0","endTime":"0","summary":"06月19日, 智翔金泰-U股价跌1.73%，报收27.32元，成交金额7679.5万元，换手率2.45%，振幅4.06%，量比0.52。智翔金泰-U今日主力资金净流出695.5万元，上一交易日主力净流入291.2万元。该股近5个交易日下跌12.46%，主力资金累计净流出3172.7万元；近20日主力资金累计净流入5143.3万元，其中净流入天数为11日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619171929a4b2465c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250619171929a4b2465c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688443"],"gpt_icon":0},{"id":"2544501919","title":"智翔金泰-U06月17日主力净流出396.6万元 散户资金买入","url":"https://stock-news.laohu8.com/highlight/detail?id=2544501919","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544501919?lang=zh_cn&edition=full","pubTime":"2025-06-17 15:20","pubTimestamp":1750144846,"startTime":"0","endTime":"0","summary":"06月17日, 智翔金泰-U股价跌3.70%，报收28.10元，成交金额1.3亿元，换手率3.97%，振幅5.79%，量比0.61。智翔金泰-U今日主力资金净流出396.6万元，上一交易日主力净流入279.7万元。|06月17日主力加仓幅度排名||#|股票简称|主力净额占比|#|胜通能源|8.61%|#|爱朋医疗|6.73%|#|融发核电|4.93%|#|...|...|#3908|智翔金泰-U|-0.12%|智翔金泰-U所在的生物制品行业，今日主力净流出3.96亿元，行业排名27/124。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617171155a70df1b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617171155a70df1b2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK0239","688443"],"gpt_icon":0},{"id":"2543658188","title":"每周股票复盘：智翔金泰（688443）2024年股东大会与限售股上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2543658188","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543658188?lang=zh_cn&edition=full","pubTime":"2025-06-14 05:08","pubTimestamp":1749848897,"startTime":"0","endTime":"0","summary":"截至2025年6月13日收盘，智翔金泰报收于29.85元，较上周的30.12元下跌0.9%。股本股东变化：2639915股首次公开发行战略配售限售股将于2025年6月20日上市流通。公司公告汇总重庆智翔金泰生物制药股份有限公司将于2025年6月18日下午14时在重庆市江北区金源路9号重庆君豪大饭店召开2024年年度股东大会。限售股股东为海通创新证券投资有限公司，限售期为自公司股票上市之日起24个月，限售股份数量为2639915股，占公司股本总数的0.7200%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025061400008432.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688443","BK0239"],"gpt_icon":0},{"id":"2542106495","title":"智翔金泰：2025年6月20日将有263.992万股战略配售限售股上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2542106495","media":"公司公告","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542106495?lang=zh_cn&edition=full","pubTime":"2025-06-12 21:31","pubTimestamp":1749735066,"startTime":"0","endTime":"0","summary":"智翔金泰公告，公司首次公开发行的战略配售限售股将于2025年6月20日上市流通，涉及股份数量为263.992万股，占总股本比例为0.7200%，限售期为24个月。本次流通的股东为海通创新证券投资有限公司，其承诺已履行完毕。保荐机构 国泰海通 证券确认相关事项符合规定。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213903a4a549ef&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250612213903a4a549ef&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["688443","BK0239"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1753460327015,"stockEarnings":[{"period":"1week","weight":0.1093},{"period":"1month","weight":0.1827},{"period":"3month","weight":0.2633},{"period":"6month","weight":0.3588},{"period":"1year","weight":0.0958},{"period":"ytd","weight":0.3675}],"compareEarnings":[{"period":"1week","weight":0.0253},{"period":"1month","weight":0.0541},{"period":"3month","weight":0.0943},{"period":"6month","weight":0.1086},{"period":"1year","weight":0.2425},{"period":"ytd","weight":0.0758}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"重庆智翔金泰生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"9205人(较上一季度增加3.69%)","perCapita":"12675股","listingDate":"2023-06-20","address":"重庆市巴南区麻柳大道699号2号楼A区","registeredCapital":"36668万元","survey":"　　重庆智翔金泰生物制药股份有限公司的主营业务是抗体药物的研发、生产与销售。公司的主要产品是抗体药物。","listedPrice":37.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"智翔金泰(688443)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供智翔金泰(688443)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"智翔金泰,688443,智翔金泰股票,智翔金泰股票老虎,智翔金泰股票老虎国际,智翔金泰行情,智翔金泰股票行情,智翔金泰股价,智翔金泰股市,智翔金泰股票价格,智翔金泰股票交易,智翔金泰股票购买,智翔金泰股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"智翔金泰(688443)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供智翔金泰(688443)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}